Cargando…
Reciprocal regulation between GCN2 (eIF2AK4) and PERK (eIF2AK3) through the JNK-FOXO3 axis to modulate cancer drug resistance and clonal survival
Pharmaceutical inhibitors of the endoplasmic reticulum (ER)-stress modulator PERK (eIF2AK3) have demonstrated anticancer activities in combination therapies, but their effectiveness as a single agent is limited, suggesting the existence of possible compensatory cellular responses. To explore the pot...
Autores principales: | Alasiri, Glowi, Jiramongkol, Yannasittha, Trakansuebkul, Sasanan, Ke, Hui-Ling, Mahmud, Zimam, Intuyod, Kitti, Lam, Eric W.-F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
North Holland Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493713/ https://www.ncbi.nlm.nih.gov/pubmed/32615282 http://dx.doi.org/10.1016/j.mce.2020.110932 |
Ejemplares similares
-
Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells
por: Alasiri, Glowi, et al.
Publicado: (2019) -
PERK (EIF2AK3) Regulates Proinsulin Trafficking and Quality Control in the Secretory Pathway
por: Gupta, Sounak, et al.
Publicado: (2010) -
Neurodegeneration risk factor, EIF2AK3 (PERK), influences tau protein aggregation
por: Park, Goonho, et al.
Publicado: (2022) -
Nucleofection induces transient eIF2α phosphorylation by GCN2 and PERK
por: Anderson, Bart R., et al.
Publicado: (2012) -
Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation
por: Aimjongjun, Sathid, et al.
Publicado: (2019)